COLUMBIA WANGER ASSET MANAGEMENT LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
COLUMBIA WANGER ASSET MANAGEMENT LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2017$30,593,000
+105.8%
10,772,111
+107.2%
0.46%
+107.7%
Q3 2017$14,865,000
-29.4%
5,197,658
-39.0%
0.22%
-26.9%
Q2 2017$21,061,000
-3.1%
8,526,619
+41.6%
0.30%
-1.3%
Q1 2017$21,731,000
-0.9%
6,019,590
-2.8%
0.30%
-1.0%
Q4 2016$21,933,000
+86.7%
6,195,855
+113.1%
0.31%
+100.0%
Q3 2016$11,746,000
-49.2%
2,907,523
-44.7%
0.15%
-42.5%
Q2 2016$23,100,000
+105.3%
5,261,934
+76.8%
0.27%
+121.5%
Q1 2016$11,251,000
-80.1%
2,976,400
-17.6%
0.12%
-78.7%
Q4 2015$56,605,000
+72.7%
3,610,008
+16.1%
0.57%
+117.2%
Q3 2015$32,775,000
-49.9%
3,109,615
+20.0%
0.26%
-37.9%
Q2 2015$65,363,000
-16.3%
2,591,703
-7.5%
0.42%
-0.9%
Q1 2015$78,056,000
+33.8%
2,800,700
-12.4%
0.42%
+46.7%
Q4 2014$58,340,000
+26.0%
3,196,700
-10.5%
0.29%
+35.7%
Q3 2014$46,288,000
-20.9%
3,571,600
-0.3%
0.21%
-9.4%
Q2 2014$58,484,000
+23.9%
3,583,600
+34.1%
0.24%
+26.3%
Q1 2014$47,214,000
+16.7%
2,672,000
+59.9%
0.19%
+20.0%
Q4 2013$40,455,0001,671,0000.16%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2016
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders